Upgrade to SI Premium - Free Trial

Dr. Reddys Labs (RDY)

11.97 -0.06 (0.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/23/26)

Latest Headlines

Form 6-K DR REDDYS LABORATORIES For: Aug 26 August 26, 2026 1:54 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Aug 14 August 17, 2026 6:58 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Aug 14 August 17, 2026 6:40 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Aug 13 August 13, 2026 9:52 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Aug 07 August 10, 2026 12:18 PM - SEC Filing Dr. Reddy's launches generic version of Bridion in the US August 4, 2026 1:39 AM - StreetInsider Dr. Reddy’s Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United State August 4, 2026 1:39 AM - BizWire Form 6-K DR REDDYS LABORATORIES For: Aug 01 August 3, 2026 6:25 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 29 July 29, 2026 2:00 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 28 July 29, 2026 6:07 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 23 July 23, 2026 2:40 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 23 July 23, 2026 2:32 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 23 July 23, 2026 12:18 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 23 July 23, 2026 11:57 AM - SEC Filing Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,275 at ICICI Securities July 23, 2026 8:06 AM - StreetInsider Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,100 at JPMorgan July 23, 2026 6:42 AM - StreetInsider Form 6-K DR REDDYS LABORATORIES For: Jul 23 July 23, 2026 6:21 AM - SEC Filing Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,050 at Goldman Sachs July 23, 2026 3:07 AM - StreetInsider Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,600 at Investec July 23, 2026 1:16 AM - StreetInsider Form 6-K DR REDDYS LABORATORIES For: Jul 22 July 22, 2026 1:59 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 22 July 22, 2026 1:36 PM - SEC Filing Dr. Reddys Labs (RDY) Misses Q2 EPS by 3c July 22, 2026 9:51 AM - StreetInsider Form 6-K DR REDDYS LABORATORIES For: Jul 22 July 22, 2026 8:35 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 22 July 22, 2026 8:31 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 22 July 22, 2026 8:27 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 15 July 15, 2026 9:46 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 13 July 13, 2026 6:36 AM - SEC Filing Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Lowered to INR1,160 at Kotak July 10, 2026 7:11 AM - StreetInsider Form 6-K DR REDDYS LABORATORIES For: Jul 10 July 10, 2026 6:21 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 09 July 9, 2026 6:18 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jun 30 July 1, 2026 7:14 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jul 01 July 1, 2026 7:07 AM - SEC Filing Jefferies Reiterates Underperform Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) July 1, 2026 5:28 AM - StreetInsider Form 6-K DR REDDYS LABORATORIES For: Jun 30 June 30, 2026 1:57 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jun 30 June 30, 2026 1:38 PM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jun 30 June 30, 2026 1:32 PM - SEC Filing Nomura/Instinet Reiterates Buy Rating on Dr. Reddy\'s Laboratories (DRRD:IN) (RDY) June 28, 2026 8:24 AM - StreetInsider Form 6-K DR REDDYS LABORATORIES For: Jun 25 June 26, 2026 11:59 AM - SEC Filing Dr. Reddy’s Laboratories Limited Announces Filing of Annual Report on Form 20-F June 26, 2026 11:10 AM - BizWire Form 6-K DR REDDYS LABORATORIES For: Jun 22 June 22, 2026 1:38 PM - SEC Filing Dr. Reddy's Laboratories (DRRD:IN) (RDY) PT Raised to INR1,740 at Nomura/Instinet June 22, 2026 6:54 AM - StreetInsider Form 6-K DR REDDYS LABORATORIES For: Jun 20 June 22, 2026 6:27 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jun 19 June 22, 2026 6:24 AM - SEC Filing Form 6-K DR REDDYS LABORATORIES For: Jun 13 June 15, 2026 6:19 AM - SEC Filing Dr. Reddy’s Announces the First-to-Market Launch of Bosutinib Tablets 400mg, a Generic Equivalent of Bosulif®, in the United States June 13, 2026 6:22 AM - BizWire Form 6-K DR REDDYS LABORATORIES For: Jun 10 June 10, 2026 11:28 AM - SEC Filing Full Article List